Aslan Pharmaceuticals Ltd. is a clinical-stage immunology biopharmaceutical company, which develops novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease. Its pipeline includes ASLAN003 and Eblasakimab. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of ASLAN Pharmaceuticals Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ASLAN Pharmaceuticals Ltd - ADR market cap is $1.7M.
What is the 52-week high for ASLAN Pharmaceuticals Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ASLAN Pharmaceuticals Ltd - ADR 52 week high is $4.32 as of September 08, 2025.
What is the 52-week low for ASLAN Pharmaceuticals Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ASLAN Pharmaceuticals Ltd - ADR 52 week low is $0.475 as of September 08, 2025.
What is ASLAN Pharmaceuticals Ltd - ADR stock price today?
ASLAN Pharmaceuticals Ltd - ADR stock price today is $0.60.
What was ASLAN Pharmaceuticals Ltd - ADR stock price yesterday?
ASLAN Pharmaceuticals Ltd - ADR stock price yesterday was $0.6999.
What is the PE ratio of ASLAN Pharmaceuticals Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ASLAN Pharmaceuticals Ltd - ADR’s P/E ratio is -0.04.
What is the Price-to-Book ratio of ASLAN Pharmaceuticals Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ASLAN Pharmaceuticals Ltd - ADR P/B ratio is -0.0945.
What is the 50-day moving average of ASLAN Pharmaceuticals Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ASLAN Pharmaceuticals Ltd - ADR 50-day moving average is $0.60.